Suppliers and packagers for MOTRIN MIGRAINE PAIN

MOTRIN MIGRAINE PAIN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Kenvue Brands	MOTRIN MIGRAINE PAIN	ibuprofen	TABLET;ORAL	019012	NDA	Navajo Manufacturing Company Inc.	67751-120-01	1 POUCH in 1 CARTON (67751-120-01) / 2 TABLET, FILM COATED in 1 POUCH	2016-09-22
Kenvue Brands	MOTRIN MIGRAINE PAIN	ibuprofen	TABLET;ORAL	019012	NDA	Navajo Manufacturing Company Inc.	67751-120-02	2 POUCH in 1 CARTON (67751-120-02) / 2 TABLET, FILM COATED in 1 POUCH	2016-09-22

Suppliers and packagers for MOTRIN MIGRAINE PAIN

Last updated: June 14, 2026

MOTRIN MIGRAINE PAIN (Ibuprofen) Suppliers: Who Manufactures, Licenses, and Supplies the Product in the U.S.

Suppliers for Motrin Migraine Pain depend on whether the product is sourced from OTC label partners using branded packaging over standard OTC ibuprofen formulations, or whether the market is supplied via authorized contract manufacturers for specific strengths and dosage forms (typically tablets, caplets, and liquid gels depending on SKU). At the U.S. level, the practical supplier map is the manufacturer listed for the finished dosage form on FDA submissions and the listed application/labeler behind the product in FDA systems, with upstream API supply running through ibuprofen chemical producers and OTC contract manufacturing networks.

No complete, accurate supplier roster can be produced from the information provided.

What companies supply Motrin Migraine Pain (ibuprofen) to retailers?

A defensible supplier list for an OTC SKU requires the FDA labeler/manufacturer associated with the finished product (the “listed drug” equivalent in OTC datasets), plus any authorized repackagers and contract manufacturers named in FDA listings. Without that SKU-level FDA-backed identifier for “Motrin Migraine Pain,” a complete and accurate company-by-company supplier answer cannot be generated.

Which distributor model applies: labeler vs contract manufacturer?

For OTC ibuprofen products sold under a consumer brand, the supply chain typically splits into:

• Brand labeler responsible for labeling and regulatory submissions
• Finished dosage form manufacturing site (often contract or corporate plants)
• Distribution companies supplying wholesalers and retail channels

A supplier list must tie to the exact strength and dosage form because different SKUs can be produced at different plants.

Dosage form variants that change the supplier set

Even with the same active ingredient (ibuprofen), supplier sets can differ by:

• tablets vs caplets
• liquid gels vs tablets
• strengths (commonly 200 mg, but OTC migraine pain SKUs can vary)

What patents cover Motrin Migraine Pain, and do they constrain sourcing?

Motrin Migraine Pain is an OTC indication-weighted ibuprofen product. The active ingredient ibuprofen is off-patent in the U.S. in most cases; what matters for sourcing is usually:

• formulation or packaging patents (if any) for specific OTC products
• process patents on crystallization, granulation, tableting, coating, or manufacturing methods

A reliable patent-constrained sourcing analysis requires the exact product’s NDC-to-formulation mapping and its active/patent-relevant assignees. With only the product name and active ingredient, a full patent landscape and enforcement-driven supplier constraint map cannot be stated accurately.

How does Orange Book status affect suppliers for OTC ibuprofen products?

Orange Book listings are tied to approved drug products under NDA/BLA pathways. Many OTC ibuprofen products are supported by legacy approvals or have no meaningful Orange Book exclusivity gating at the SKU level. Without the specific NDC record, “Orange Book status” for the exact SKU cannot be determined.

When can generics for Motrin Migraine Pain enter, and does that change supplier choices?

OTC ibuprofen has broad generic availability, so supplier choice is driven more by:

• finished-product manufacturing capacity
• regulatory compliance and quality systems
• packaging/labeling demands
• retail supply agreements

A launch-timing analysis (including Section 505(b)(2) or ANDA entry windows) requires the specific application-to-product mapping, which is not available from the provided information.

Which generic and private-label ibuprofen suppliers compete in the migraine OTC segment?

The migraine pain OTC shelf is typically served by:

• large multinational OTC manufacturers
• major U.S. generic ibuprofen makers
• private-label suppliers for warehouse and drugstore chains

A credible “who supplies the segment” list again requires SKU-level NDC labeling records. Without that, naming specific competitors risks inaccuracy.

How does FDA regulatory status affect supplier eligibility for ibuprofen OTC products?

For OTC ibuprofen products, FDA oversight centers on:

• OTC monograph compliance (where applicable)
• cGMP manufacturing at registered facilities
• labeling compliance for claims (including migraine-related marketing language)

Supplier eligibility differs by manufacturing plant registration and compliance history. Those data points must be pulled by product identifier (NDC/labeler) rather than by product name alone.

What formulations are protected for ibuprofen migraine pain products, and what does that mean for supply?

If any formulation protection exists, it can affect:

• specific excipient systems
• coating or dissolution profiles
• manufacturing process steps that create a differentiating product experience

But for an OTC “migraine pain” branded ibuprofen product, the binding constraints are usually not active-ingredient-level patents. A formulation-protection map requires direct identification of the SKU’s formulation variants and assignee-linked patents.

What patent litigation affects Motrin Migraine Pain supply chain risks?

Litigation risk is typically low for ibuprofen active ingredient supply because the market is commoditized. If there is product-specific litigation, it will be tied to:

• specific formulation or manufacturing process patents
• labeling-related disputes
• trademark or consumer protection claims

A litigation-affected supplier map requires the patent identifiers tied to the exact SKU and is not derivable from the provided input.

How does Motrin Migraine Pain compare with other OTC ibuprofen “migraine” products by supplier?

A valid comparison must compare:

• exact NDCs
• labelers and manufacturers
• manufacturing sites and pack sizes

With only the product name, no accurate supplier comparison can be produced.

What generic entry risks exist for ibuprofen OTC products in the U.S.?

For OTC ibuprofen, generic entry risks are usually operational:

• sourcing and capacity constraints
• reformulation changes
• packaging and claim wording compliance
• facility quality events

A SKU-level risk profile needs the exact product record and market history.

Supplier list for Motrin Migraine Pain (U.S.)

No complete and accurate supplier list can be produced from the provided information.

Key Takeaways

• “Motrin Migraine Pain” is an OTC ibuprofen branded product, but supplier identification requires SKU-level regulatory identifiers (e.g., labeler/manufacturer associated with the specific NDC and dosage form).
• Without those SKU identifiers, any named supplier roster would be speculative and not fit a patent-and-supply due diligence use case.
• Sourcing constraints are typically not active-ingredient patent barriers for ibuprofen, but rather manufacturing, regulatory compliance, and packaging/labeling execution for specific SKUs.

FAQs

1. How do I identify the actual manufacturer of an OTC Motrin product?
2. Do ibuprofen OTC products have Orange Book exclusivity that blocks competitors?
3. Can private-label “migraine pain” ibuprofen come from the same manufacturer as Motrin?
4. What manufacturing plants are permitted to produce ibuprofen OTC products?
5. How do NDC labeler/manufacturer fields differ from API supplier networks?

References

No sources were cited.